A randomised, double blind trial will be testing the efficacy of a nasal spray to protect frontline healthcare workers against COVID-19. The spray is the first Austrian SARS-CoV-2 prophylactic treatment to be tested in 334 individuals at two clinical sites in Vienna, Austria. Marinomed Biotech AG, a globally operating biopharmaceutical company, will be carrying out [ ]
The post Nasal spray clinical trial to investigate prevention of COVID-19 infection appeared first on Health Europa.
Thursday 21 January 2021
healtheuropa - 2 month ago
Nasal spray clinical trial to investigate prevention of COVID-19 infection
Latest News
⁞
Sources